SynthesisBMC cancer2025

Assessing the clinical outcomes of immunotherapy and docetaxel combinations in metastatic castration-resistant prostate cancer: a meta-analysis.

Azka Syed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.